Insights

Expanding Facility Footprint BioVectra's recent $90 million expansion, including the opening of new facilities in Prince Edward Island and Nova Scotia, indicates a strong growth trajectory and increased capacity. This expansion presents opportunities to offer specialized biomanufacturing services and supply chain support to this rapidly scaling organization.

Award-Winning Leadership Receiving the 2025 CDMO Leadership Award positions BioVectra as a recognized leader in biologics manufacturing, enhancing its visibility among biopharmaceutical companies seeking reliable, high-quality CDMO partners for complex molecular development and production.

Technological Integration The integration with Revolution Biomanufacturing’s advanced sequence optimization technology signals BioVectra's commitment to innovation and process robustness, making it an attractive partner for clients with cutting-edge biologics and gene therapy projects requiring seamless workflows and reduced risk.

Market Position and Growth Funding With a solid revenue base between $50 million and $100 million and recent funding of $40 million, BioVectra demonstrates financial stability and growth potential, offering prospects for strategic partnerships, joint ventures, or co-development opportunities focused on novel therapeutics.

Diversified Industry Focus BioVectra's expertise spans biologics, small molecules, mRNA, and highly potent APIs, catering to a broad range of biotech and pharmaceutical clients. This diversification provides multiple sales channels for service offerings, including early-stage development, clinical manufacturing, and commercial supply.

BIOVECTRA Tech Stack

BIOVECTRA uses 8 technology products and services including Fusion Ads, Blackline, Modernizr, and more. Explore BIOVECTRA's tech stack below.

  • Fusion Ads
    Advertising
  • Blackline
    Corporate Performance Management
  • Modernizr
    Javascript Libraries
  • Ceridian Payroll
    Payroll Management And Benefits Administration
  • Cloudflare Bot Management
    Security
  • Minitab
    Visualisation Software
  • Autoptimize
    Web Platform Extensions
  • Ivory Search
    Web Platform Extensions

Media & News

BIOVECTRA's Email Address Formats

BIOVECTRA uses at least 1 format(s):
BIOVECTRA Email FormatsExamplePercentage
FLast@biovectra.comJDoe@biovectra.com
97%
FiLast@biovectra.comJoDoe@biovectra.com
1%
FMiddleLast@biovectra.comJMichaelDoe@biovectra.com
1%
LFirst@biovectra.comDJohn@biovectra.com
1%

Frequently Asked Questions

What is BIOVECTRA's phone number?

Minus sign iconPlus sign icon
You can contact BIOVECTRA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIOVECTRA's official website and social media links?

Minus sign iconPlus sign icon
BIOVECTRA's official website is biovectra.com and has social profiles on LinkedIn.

How much revenue does BIOVECTRA generate?

Minus sign iconPlus sign icon
As of December 2025, BIOVECTRA's annual revenue is estimated to be $20M.

What is BIOVECTRA's SIC code NAICS code?

Minus sign iconPlus sign icon
BIOVECTRA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOVECTRA have currently?

Minus sign iconPlus sign icon
As of December 2025, BIOVECTRA has approximately 601 employees across 2 continents, including North AmericaEurope. Key team members include Chief Operating Officer: T. D.Chief Commercial Officer: H. D.Vice President & General Manager, Biologics: S. D.. Explore BIOVECTRA's employee directory with LeadIQ.

What industry does BIOVECTRA belong to?

Minus sign iconPlus sign icon
BIOVECTRA operates in the Biotechnology Research industry.

What technology does BIOVECTRA use?

Minus sign iconPlus sign icon
BIOVECTRA's tech stack includes Fusion AdsBlacklineModernizrCeridian PayrollCloudflare Bot ManagementMinitabAutoptimizeIvory Search.

What is BIOVECTRA's email format?

Minus sign iconPlus sign icon
BIOVECTRA's email format typically follows the pattern of FLast@biovectra.com. Find more BIOVECTRA email formats with LeadIQ.

How much funding has BIOVECTRA raised to date?

Minus sign iconPlus sign icon
As of December 2025, BIOVECTRA has raised $40M in funding. The last funding round occurred on Mar 03, 2019 for $38M.

When was BIOVECTRA founded?

Minus sign iconPlus sign icon
BIOVECTRA was founded in 1970.

BIOVECTRA

Biotechnology ResearchPrince Edward Island, Canada501-1000 Employees

Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We are a forward-thinking, North American CDMO Pharmaceutical company  specializing in clinical-to-commercial scale production capabilities for:
Biologics
Synthetic small molecules 
Fermented small molecules
Highly potent APIs
Bioreagents
mRNA, pDNA, LNP manufacturing
Fill/Finish

Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1970
Employees
501-1000

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $40M

    BIOVECTRA has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Mar 03, 2019 in the amount of $38Mas a investment.

  • $50M$100M

    BIOVECTRA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.